ACTG1 and cancer: However, experiments are needed to show this causative effect and to rule out the possibility that the observed enrichment of ACTB or ACTG1 mutations in these two cancer types reflect a higher tolerance for such mutations compared to other cancer types in which they are therefore less detected.